Pages that link to "Q73707363"

The following pages link to 7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week (Q73707363):

Displaying 17 items.

• Cardioprotective interventions for cancer patients receiving anthracyclines (Q24236338) (← links)
• Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity (Q26744634) (← links)
• An essential difference between the flavonoids monoHER and quercetin in their interplay with the endogenous antioxidant network (Q28476023) (← links)
• Chemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer Cells (Q28816971) (← links)
• Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies (Q33812953) (← links)
• Evaluation of the mutagenicity and antimutagenicity of Ziziphus joazeiro Mart. bark in the micronucleus assay. (Q33890365) (← links)
• Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin. (Q34571662) (← links)
• Total Flavonoids from Clinopodium chinense (Benth.) O. Ktze Protect against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo (Q35136498) (← links)
• Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells. (Q36609796) (← links)
• Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice (Q36610126) (← links)
• The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study (Q36611388) (← links)
• The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro (Q36670985) (← links)
• A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro (Q38303842) (← links)
• Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity (Q38838517) (← links)
• Acacia hydaspica R. Parker prevents doxorubicin-induced cardiac injury by attenuation of oxidative stress and structural Cardiomyocyte alterations in rats (Q47109333) (← links)
• Effect of Acacia hydaspica R. Parker extract on lipid peroxidation, antioxidant status, liver function test and histopathology in doxorubicin treated rats. (Q64980409) (← links)
• Doxorubicin-induced alterations in kidney functioning, oxidative stress, DNA damage, and renal tissue morphology; Improvement by Acacia hydaspica tannin-rich ethyl acetate fraction (Q98945605) (← links)